⌘K
Loading ticker…
As of 2026-08-24, United Therapeutics Corp (UTHR) has a 3-month relative strength percentile of 30 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.7%, relative volume 0.60×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
UTHR is in a stage 3 topping pattern, week 1. Currently in a 75-day base; basing ADR 2.5% (broad 3.0%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: -3.7% / -1.6%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
UTHR is held by 65 ETFs as of May 2026. Top owner: VHT at 0.36% weight, $68M notional. Top 3 carry $172M.
Held by 219 ETFs · $5.4B across latest filings · largest weight 8.77% (PINK).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VHTVanguard Health Care ETF | 0.36% | $68M | +0.04 pp |
| SCHMSchwab U.S. Mid-Cap ETF | 0.44% | $65M | +0.01 pp |
| IVOO | 0.68% | $38M | +0.05 pp |
| SCHXSchwab U.S. Large-Cap ETF | 0.03% | $25M | — |
| OMFL | 0.51% | $24M | +0.41 pp |
| IVOG | 1.31% | $24M | +0.10 pp |
| VONVVanguard Russell 1000 Value ETF | 0.07% | $15M | — |
| SCHBSchwab U.S. Broad Market ETF | 0.03% | $14M | — |
| QQQJ | 1.13% | $13M | +0.06 pp |
| AVUSAvantis U.S. Equity ETF | 0.09% | $12M | — |
Showing 10 of 65 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | UTHR Jan avg: -2.95% median: -2.98% win: 0% σ: 2.07% n: 4 2022-04-12 → 2026-07-31 | UTHR Feb avg: -0.75% median: -0.73% win: 50% σ: 8.12% n: 4 2022-04-12 → 2026-07-31 | UTHR Mar avg: 1.71% median: -0.94% win: 50% σ: 11.52% n: 4 2022-04-12 → 2026-07-31 | UTHR Apr avg: -0.97% median: -1.68% win: 40% σ: 3.22% n: 5 2022-04-12 → 2026-07-31 | UTHR May avg: 8.19% median: 5.20% win: 60% σ: 15.52% n: 5 2022-04-12 → 2026-07-31 | UTHR Jun avg: 2.15% median: 2.30% win: 60% σ: 9.53% n: 5 2022-04-12 → 2026-07-31 | UTHR Jul avg: -0.50% median: -1.94% win: 20% σ: 5.99% n: 5 2022-04-12 → 2026-07-31 | UTHR Aug avg: 4.37% median: 4.51% win: 50% σ: 10.98% n: 4 2022-04-12 → 2026-07-31 (current) | UTHR Sep avg: 7.30% median: -0.38% win: 50% σ: 20.47% n: 4 2022-04-12 → 2026-07-31 | UTHR Oct avg: 4.85% median: 5.31% win: 75% σ: 4.76% n: 4 2022-04-12 → 2026-07-31 | UTHR Nov avg: 9.32% median: 8.40% win: 75% σ: 9.20% n: 4 2022-04-12 → 2026-07-31 | UTHR Dec avg: -3.38% median: -2.70% win: 25% σ: 3.98% n: 4 2022-04-12 → 2026-07-31 |